// App-Quantinova.ai

: Outcomes of MRD-Adapted Treatment Modulation in Patients with Newly Diagnosed Multiple Myeloma Receiving Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) and Autologous Transplantation: Extended Follow up of the Master Trial

Researchers

Presenter

  • Luciano J. Costa

Principal Investigators

  • Saurabh Chhabra

  • Eva Medvedova

  • Timothy Martin Schmidt

  • Bhagirathbhai Dholaria

  • Kelly N. Godby

  • Rebecca Silbermann

  • Susan Bal

  • Anita D'Souza

  • Smith Giri

  • James L. Omel

  • Parameswaran Hari

  • Natalie Callander

  • Binod Dhakal

Medical Centers

  • Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

  • Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

  • O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL

  • Medical College of Wisconsin, Department of Medicine, Milwaukee, WI

  • Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

  • Division of Hematology Oncology, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

  • Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN

  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR

  • University of Alabama at Birmingham, Birmingham, AL

  • University of Wisconsin Carbone Cancer Center, Madison, WI

  • Carbone Cancer Center, University of Wisconsin, Madison, WI

  • Myeloma Research Advocate/Advisor, Grand Island, NE

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • carfilzomib Intravenous

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved